guest ::
| Home > Publications database > Molecular subtyping of gastric cancer with respect to the growth pattern of lymph-node metastases. > print |
| Home > Publications database > Molecular subtyping of gastric cancer with respect to the growth pattern of lymph-node metastases. > print |
| 001 | 144854 | ||
| 005 | 20240229112640.0 | ||
| 024 | 7 | _ | |a 10.1007/s00432-019-03029-4 |2 doi |
| 024 | 7 | _ | |a pmid:31541339 |2 pmid |
| 024 | 7 | _ | |a 0084-5353 |2 ISSN |
| 024 | 7 | _ | |a 0171-5216 |2 ISSN |
| 024 | 7 | _ | |a 0943-9382 |2 ISSN |
| 024 | 7 | _ | |a 1432-1335 |2 ISSN |
| 024 | 7 | _ | |a altmetric:66962675 |2 altmetric |
| 037 | _ | _ | |a DKFZ-2019-02278 |
| 041 | _ | _ | |a eng |
| 082 | _ | _ | |a 610 |
| 100 | 1 | _ | |a Bösch, Florian |0 0000-0002-0250-9017 |b 0 |
| 245 | _ | _ | |a Molecular subtyping of gastric cancer with respect to the growth pattern of lymph-node metastases. |
| 260 | _ | _ | |a Berlin |c 2019 |b Springer42162 |
| 264 | _ | 1 | |3 online |2 Crossref |b Springer Science and Business Media LLC |c 2019-09-20 |
| 264 | _ | 1 | |3 print |2 Crossref |b Springer Science and Business Media LLC |c 2019-11-01 |
| 264 | _ | 1 | |3 print |2 Crossref |b Springer Science and Business Media LLC |c 2019-11-01 |
| 336 | 7 | _ | |a article |2 DRIVER |
| 336 | 7 | _ | |a Output Types/Journal article |2 DataCite |
| 336 | 7 | _ | |a Journal Article |b journal |m journal |0 PUB:(DE-HGF)16 |s 1577095058_24059 |2 PUB:(DE-HGF) |
| 336 | 7 | _ | |a ARTICLE |2 BibTeX |
| 336 | 7 | _ | |a JOURNAL_ARTICLE |2 ORCID |
| 336 | 7 | _ | |a Journal Article |0 0 |2 EndNote |
| 520 | _ | _ | |a Gastric cancer is the third leading cause of cancer-related death. Recently, innovative diagnostic and prognostic molecular subtypes have been proposed. We revealed that extranodal extension (ENE) of lymph-node metastases independently influences survival. Therefore, the aim of the present study was to evaluate novel molecular subtyping with regard to the growth pattern of lymph-node metastases.A total of 189 gastric carcinomas with lymph-node metastases were analyzed. The expression of p53, SOX2, SOX9, and the mismatch-repair gene products MLH1, PMS2, MSH2, and MSH6 were analyzed by immunohistochemistry. To determine the correlation with EBV infection, in situ hybridization for EBV-encoded small RNA (EBER) was applied.ENE was present in 36% of patients. EBV-positive carcinoma was evident in 5.8%, and p53 aberrant (chromosomal instable) tumors in 22.2%, a gastric cancer with deficient mismatch-repair status in 9%, and MSS/p53neg/EBVneg tumors were seen in 63% of patients. There was no significant correlation between the presence or absence of ENE and the molecular subtypes. However, a significant association between molecular subgroups and the Lauren classification, the oncogene SOX2, and tumor grading was detected.The present findings suggest that alterations in gastric cancer leading to ENE are not associated with alterations underpinning the molecular subgroups. Nonetheless, molecular subtyping on the basis of IHC and ISH is feasible and might become clinical routine. Thus, further studies are needed to clarify the mechanisms of extranodal extension in gastric cancer. |
| 536 | _ | _ | |a 315 - Imaging and radiooncology (POF3-315) |0 G:(DE-HGF)POF3-315 |c POF3-315 |f POF III |x 0 |
| 542 | _ | _ | |i 2019-09-20 |2 Crossref |u http://www.springer.com/tdm |
| 542 | _ | _ | |i 2019-09-20 |2 Crossref |u http://www.springer.com/tdm |
| 588 | _ | _ | |a Dataset connected to CrossRef, PubMed, |
| 700 | 1 | _ | |a Todorova, Rumyana |b 1 |
| 700 | 1 | _ | |a Link, Helena |b 2 |
| 700 | 1 | _ | |a Westphalen, C Benedikt |b 3 |
| 700 | 1 | _ | |a Boeck, Stefan |b 4 |
| 700 | 1 | _ | |a Heinemann, Volker |b 5 |
| 700 | 1 | _ | |a Werner, Jens |b 6 |
| 700 | 1 | _ | |a Kirchner, Thomas |0 P:(DE-He78)fd68f49dada874ac262fadf9fde869df |b 7 |u dkfz |
| 700 | 1 | _ | |a Angele, Martin K |b 8 |
| 700 | 1 | _ | |a Neumann, Jens |0 P:(DE-HGF)0 |b 9 |e Last author |
| 773 | 1 | 8 | |a 10.1007/s00432-019-03029-4 |b Springer Science and Business Media LLC |d 2019-09-20 |n 11 |p 2689-2697 |3 journal-article |2 Crossref |t Journal of Cancer Research and Clinical Oncology |v 145 |y 2019 |x 0171-5216 |
| 773 | _ | _ | |a 10.1007/s00432-019-03029-4 |0 PERI:(DE-600)1459285-X |n 11 |p 2689-2697 |t Journal of cancer research and clinical oncology |v 145 |y 2019 |x 0171-5216 |
| 909 | C | O | |p VDB |o oai:inrepo02.dkfz.de:144854 |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 7 |6 P:(DE-He78)fd68f49dada874ac262fadf9fde869df |
| 913 | 1 | _ | |a DE-HGF |l Krebsforschung |1 G:(DE-HGF)POF3-310 |0 G:(DE-HGF)POF3-315 |2 G:(DE-HGF)POF3-300 |v Imaging and radiooncology |x 0 |4 G:(DE-HGF)POF |3 G:(DE-HGF)POF3 |b Gesundheit |
| 914 | 1 | _ | |y 2019 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0200 |2 StatID |b SCOPUS |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0300 |2 StatID |b Medline |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0310 |2 StatID |b NCBI Molecular Biology Database |
| 915 | _ | _ | |a JCR |0 StatID:(DE-HGF)0100 |2 StatID |b J CANCER RES CLIN : 2015 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0600 |2 StatID |b Ebsco Academic Search |
| 915 | _ | _ | |a Peer Review |0 StatID:(DE-HGF)0030 |2 StatID |b ASC |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0199 |2 StatID |b Thomson Reuters Master Journal List |
| 915 | _ | _ | |a WoS |0 StatID:(DE-HGF)0110 |2 StatID |b Science Citation Index |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0150 |2 StatID |b Web of Science Core Collection |
| 915 | _ | _ | |a WoS |0 StatID:(DE-HGF)0111 |2 StatID |b Science Citation Index Expanded |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1030 |2 StatID |b Current Contents - Life Sciences |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1050 |2 StatID |b BIOSIS Previews |
| 915 | _ | _ | |a IF < 5 |0 StatID:(DE-HGF)9900 |2 StatID |
| 920 | 1 | _ | |0 I:(DE-He78)E131-20160331 |k E131 |l Computer-assistierte Interventionen |x 0 |
| 920 | 1 | _ | |0 I:(DE-He78)L101-20160331 |k L101 |l DKTK Heidelberg |x 1 |
| 980 | _ | _ | |a journal |
| 980 | _ | _ | |a VDB |
| 980 | _ | _ | |a I:(DE-He78)E131-20160331 |
| 980 | _ | _ | |a I:(DE-He78)L101-20160331 |
| 980 | _ | _ | |a UNRESTRICTED |
| 999 | C | 5 | |a 10.1097/PAS.0000000000000756 |9 -- missing cx lookup -- |1 S Ahn |p 106 - |2 Crossref |u Ahn S, Lee SJ, Kim Y, Kim A, Shin N et al (2017) High-throughput protein and mRNA expression-based classification of gastric cancers can identify clinically distinct subtypes, concordant with recent molecular classifications. Am J Surg Pathol 41:106–115. https://doi.org/10.1097/PAS.0000000000000756 |t Am J Surg Pathol |v 41 |y 2017 |
| 999 | C | 5 | |a 10.1002/cncr.24764 |9 -- missing cx lookup -- |1 H Alakus |p 309 - |2 Crossref |u Alakus H, Holscher AH, Grass G, Hartmann E, Schulte C et al (2010) Extranodal lymph node spread: a new prognostic factor in gastric cancer. Cancer 116:309–315. https://doi.org/10.1002/cncr.24764 |t Cancer |v 116 |y 2010 |
| 999 | C | 5 | |a 10.1007/s00428-017-2240-x |9 -- missing cx lookup -- |1 EM Birkman |p 369 - |2 Crossref |u Birkman EM, Mansuri N, Kurki S, Algars A, Lintunen M et al (2018) Gastric cancer: immunohistochemical classification of molecular subtypes and their association with clinicopathological characteristics. Virchows Arch 472:369–382. https://doi.org/10.1007/s00428-017-2240-x |t Virchows Arch |v 472 |y 2018 |
| 999 | C | 5 | |a 10.1530/ERC-18-0494 |9 -- missing cx lookup -- |1 F Bosch |p 293 - |2 Crossref |u Bosch F, Bruwer K, Altendorf-Hofmann A, Auernhammer CJ, Spitzweg C et al (2019) Immune checkpoint markers in gastroenteropancreatic neuroendocrine neoplasia. Endocr Relat Cancer 26:293–301. https://doi.org/10.1530/ERC-18-0494 |t Endocr Relat Cancer |v 26 |y 2019 |
| 999 | C | 5 | |a 10.1038/nature13480 |9 -- missing cx lookup -- |1 Cancer Genome Atlas Research N |p 202 - |2 Crossref |u Cancer Genome Atlas Research N (2014) Comprehensive molecular characterization of gastric adenocarcinoma. Nature 513:202–209. https://doi.org/10.1038/nature13480 |t Nature |v 513 |y 2014 |
| 999 | C | 5 | |a 10.1038/nm.3850 |9 -- missing cx lookup -- |1 R Cristescu |p 449 - |2 Crossref |u Cristescu R, Lee J, Nebozhyn M, Kim KM, Ting JC et al (2015) Molecular analysis of gastric cancer identifies subtypes associated with distinct clinical outcomes. Nat Med 21:449–456. https://doi.org/10.1038/nm.3850 |t Nat Med |v 21 |y 2015 |
| 999 | C | 5 | |a 10.1056/NEJMoa055531 |9 -- missing cx lookup -- |1 D Cunningham |p 11 - |2 Crossref |u Cunningham D, Allum WH, Stenning SP, Thompson JN, Van de Velde CJ et al (2006) Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med 355:11–20. https://doi.org/10.1056/NEJMoa055531 |t N Engl J Med |v 355 |y 2006 |
| 999 | C | 5 | |a 10.21037/jgo.2016.11.01 |9 -- missing cx lookup -- |1 B Fakhri |p 379 - |2 Crossref |u Fakhri B, Lim KH (2017) Molecular landscape and sub-classification of gastrointestinal cancers: a review of literature. J Gastrointest Oncol 8:379–386. https://doi.org/10.21037/jgo.2016.11.01 |t J Gastrointest Oncol |v 8 |y 2017 |
| 999 | C | 5 | |a 10.1002/ijc.29210 |9 -- missing cx lookup -- |1 J Ferlay |p E359 - |2 Crossref |u Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C et al (2015) Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 136:E359–E386. https://doi.org/10.1002/ijc.29210 |t Int J Cancer |v 136 |y 2015 |
| 999 | C | 5 | |a 10.1016/j.humpath.2016.06.003 |9 -- missing cx lookup -- |1 RS Gonzalez |p 16 - |2 Crossref |u Gonzalez RS, Messing S, Tu X, McMahon LA, Whitney-Miller CL (2016) Immunohistochemistry as a surrogate for molecular subtyping of gastric adenocarcinoma. Hum Pathol 56:16–21. https://doi.org/10.1016/j.humpath.2016.06.003 |t Hum Pathol |v 56 |y 2016 |
| 999 | C | 5 | |a 10.3978/j.issn.2078-6891.2012.021 |9 -- missing cx lookup -- |1 B Hu |p 251 - |2 Crossref |u Hu B, El Hajj N, Sittler S, Lammert N, Barnes R et al (2012) Gastric cancer: classification, histology and application of molecular pathology. J Gastrointest Oncol 3:251–261. https://doi.org/10.3978/j.issn.2078-6891.2012.021 |t J Gastrointest Oncol |v 3 |y 2012 |
| 999 | C | 5 | |a 10.1093/carcin/bgt410 |9 -- missing cx lookup -- |1 K Hutz |p 942 - |2 Crossref |u Hutz K, Mejias-Luque R, Farsakova K, Ogris M, Krebs S et al (2014) The stem cell factor SOX2 regulates the tumorigenic potential in human gastric cancer cells. Carcinogenesis 35:942–950. https://doi.org/10.1093/carcin/bgt410 |t Carcinogenesis |v 35 |y 2014 |
| 999 | C | 5 | |a 10.3322/caac.20107 |9 -- missing cx lookup -- |1 A Jemal |p 69 - |2 Crossref |u Jemal A, Bray F, Center MM, Ferlay J, Ward E et al (2011) Global cancer statistics. CA Cancer J Clin 61:69–90. https://doi.org/10.3322/caac.20107 |t CA Cancer J Clin |v 61 |y 2011 |
| 999 | C | 5 | |a 10.18632/oncotarget.10115 |9 -- missing cx lookup -- |1 HS Kim |p 44608 - |2 Crossref |u Kim HS, Shin SJ, Beom SH, Jung M, Choi YY et al (2016) Comprehensive expression profiles of gastric cancer molecular subtypes by immunohistochemistry: implications for individualized therapy. Oncotarget 7:44608–44620. https://doi.org/10.18632/oncotarget.10115 |t Oncotarget |v 7 |y 2016 |
| 999 | C | 5 | |a 10.1111/apm.1965.64.1.31 |9 -- missing cx lookup -- |1 P Lauren |p 31 - |2 Crossref |u Lauren P (1965) The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. An attempt at a histo-clinical classification. Acta Pathol Microbiol Scand 64:31–49 |t Acta Pathol Microbiol Scand |v 64 |y 1965 |
| 999 | C | 5 | |a 10.1002/bjs.9640 |9 -- missing cx lookup -- |1 IS Lee |p 1576 - |2 Crossref |u Lee IS, Park YS, Ryu MH, Song MJ, Yook JH et al (2014) Impact of extranodal extension on prognosis in lymph node-positive gastric cancer. Br J Surg 101:1576–1584. https://doi.org/10.1002/bjs.9640 |t Br J Surg |v 101 |y 2014 |
| 999 | C | 5 | |a 10.1186/s12885-018-4413-7 |9 -- missing cx lookup -- |1 H Link |p 483 - |2 Crossref |u Link H, Angele M, Schuller M, Ganschow P, Machetanz L et al (2018) Extra-capsular growth of lymph node metastasis correlates with poor prognosis and high SOX9 expression in gastric cancer. BMC Cancer 18:483. https://doi.org/10.1186/s12885-018-4413-7 |t BMC Cancer |v 18 |y 2018 |
| 999 | C | 5 | |a 10.1016/j.suronc.2015.09.005 |9 -- missing cx lookup -- |1 C Luchini |p 60 - |2 Crossref |u Luchini C, Nottegar A, Solmi M, Sergi G, Manzato E et al (2016) Prognostic implications of extranodal extension in node-positive squamous cell carcinoma of the vulva: a systematic review and meta-analysis. Surg Oncol 25:60–65. https://doi.org/10.1016/j.suronc.2015.09.005 |t Surg Oncol |v 25 |y 2016 |
| 999 | C | 5 | |a 10.1016/j.jss.2010.11.903 |9 -- missing cx lookup -- |1 J Matsuoka |p 130 - |2 Crossref |u Matsuoka J, Yashiro M, Sakurai K, Kubo N, Tanaka H et al (2012) Role of the stemness factors sox2, oct3/4, and nanog in gastric carcinoma. J Surg Res 174:130–135. https://doi.org/10.1016/j.jss.2010.11.903 |t J Surg Res |v 174 |y 2012 |
| 999 | C | 5 | |a 10.1016/S1470-2045(14)70473-5 |9 -- missing cx lookup -- |1 SH Noh |p 1389 - |2 Crossref |u Noh SH, Park SR, Yang HK, Chung HC, Chung IJ et al (2014) Adjuvant capecitabine plus oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): 5-year follow-up of an open-label, randomised phase 3 trial. Lancet Oncol 15:1389–1396. https://doi.org/10.1016/S1470-2045(14)70473-5 |t Lancet Oncol |v 15 |y 2014 |
| 999 | C | 5 | |a 10.1002/path.5208 |1 H Rokutan |9 -- missing cx lookup -- |2 Crossref |u Rokutan H, Abe H, Nakamura H, Ushiku T, Arakawa E et al (2018) Initial and crucial genetic events in intestinal-type gastric intramucosal neoplasia. J Pathol. https://doi.org/10.1002/path.5208 |t J Pathol |y 2018 |
| 999 | C | 5 | |a 10.1038/modpathol.2016.55 |9 -- missing cx lookup -- |1 N Setia |p 772 - |2 Crossref |u Setia N, Agoston AT, Han HS, Mullen JT, Duda DG et al (2016) A protein and mRNA expression-based classification of gastric cancer. Mod Pathol 29:772–784. https://doi.org/10.1038/modpathol.2016.55 |t Mod Pathol |v 29 |y 2016 |
| 999 | C | 5 | |a 10.7555/JBR.26.20120045 |9 -- missing cx lookup -- |1 T Tian |p 336 - |2 Crossref |u Tian T, Zhang Y, Wang S, Zhou J, Xu S (2012) Sox2 enhances the tumorigenicity and chemoresistance of cancer stem-like cells derived from gastric cancer. J Biomed Res 26:336–345. https://doi.org/10.7555/JBR.26.20120045 |t J Biomed Res |v 26 |y 2012 |
| 999 | C | 5 | |a 10.1093/annonc/mdv494 |9 -- missing cx lookup -- |1 N Veronese |p 42 - |2 Crossref |u Veronese N, Nottegar A, Pea A, Solmi M, Stubbs B et al (2016) Prognostic impact and implications of extranodal lymph node involvement in colorectal cancer: a systematic review with meta-analysis. Ann Oncol 27:42–48. https://doi.org/10.1093/annonc/mdv494 |t Ann Oncol |v 27 |y 2016 |
| Library | Collection | CLSMajor | CLSMinor | Language | Author |
|---|